Hepatitis B Revaccination Schedule for Adults with Negative Anti-HBs Titer
For adults with negative anti-HBs titers after completing an initial hepatitis B vaccine series, administer a complete 3-dose revaccination series using the same standard schedules (0,1,6 months for most vaccines or 0,1 month for Heplisav-B), and consider using higher-dose formulations or adjuvanted vaccines to improve response rates. 1
Standard Revaccination Approach
When an adult has completed a primary hepatitis B vaccination series but has a negative titer (anti-HBs <10 IU/L), the ACIP 2022 guidelines provide clear direction:
Vaccine Options and Schedules
You do not need to restart the series—simply administer a complete new 3-dose series using one of these options 1:
- Recombivax HB: 10 μg at 0,1, and 6 months
- Engerix-B: 20 μg at 0,1, and 6 months
- Heplisav-B: 20 μg at 0 and 1 month (2-dose series)
- PreHevbrio: 10 μg at 0,1, and 6 months
- Twinrix: 20 μg at 0,1, and 6 months
Optimizing Response in Non-Responders
For individuals who failed to respond to an initial series, consider strategies that improve seroconversion:
Higher-dose vaccines show superior response rates: Research demonstrates that revaccinating with HBVaxPro-40 (40 μg) or Fendrix (20 μg adjuvanted vaccine) resulted in significantly higher response rates (83% and 87% respectively) compared to standard-dose revaccination (67%) 2. The adjuvanted Fendrix vaccine achieved 95% seroconversion in healthcare workers who were non-responders to two prior standard courses 3.
Increased antigen dose matters: Studies confirm that 20 μg doses produce higher anti-HBs conversion rates and geometric mean titers compared to 10 μg doses in non-responders 4, 5.
Timing and Monitoring
Check anti-HBs titer 1-2 months after completing the revaccination series to document response. The protective threshold is ≥10 IU/L 1.
Important Timing Rules from ACIP Guidelines:
- Minimum interval between doses 1 and 2: 4 weeks
- Minimum interval between doses 2 and 3: 8 weeks
- Minimum interval between doses 1 and 3: 16 weeks
- If interrupted, continue where you left off—do not restart 1
Special Populations
For immunocompromised adults or those on hemodialysis who are non-responders:
- Use Engerix-B 40 μg (given as 2 mL) in a 4-dose series at 0,1,2, and 6 months, OR
- Use Recombivax HB 40 μg in a 3-dose series at 0,1, and 6 months 1
For pregnant individuals: Use Engerix-B, Recombivax HB, or Twinrix (not Heplisav-B or PreHevbrio due to insufficient safety data) 1
Common Pitfalls to Avoid
- Don't assume one booster dose is sufficient: Non-responders need a complete series, not just a single additional dose
- Don't use the same low-dose vaccine that failed initially: Consider higher-dose or adjuvanted formulations for better response
- Don't forget to check titers post-revaccination: 5-10% of healthy adults remain persistent non-responders even after multiple series 3
- Don't delay vaccination waiting for serologic testing: Testing is not required before revaccination and should not be a barrier 1
Algorithm for Persistent Non-Responders
If anti-HBs remains <10 IU/L after a second complete series:
- First choice: Administer Fendrix (adjuvanted vaccine) 3-dose series—achieves 95% seroconversion in double non-responders 3
- Alternative: HBVaxPro-40 (40 μg) 3-dose series—achieves 83% seroconversion 2
- Consider these individuals susceptible to HBV: Counsel about post-exposure prophylaxis needs and provide hepatitis B immune globulin (HBIG) if exposed
The evidence strongly supports that adjuvanted vaccines (Fendrix) or double-dose regimens (40 μg) are significantly more effective than repeating standard-dose vaccination in non-responders, with Fendrix showing the highest success rates in the most recent studies 2, 3.